Gian Franco Zannoni
Gian Franco Zannoni
Università Cattolica del Sacro Cuore
Nessuna email verificata
TitoloCitata daAnno
Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning
R Manfredi, P Mirk, G Maresca, PA Margariti, A Testa, GF Zannoni, ...
Radiology 231 (2), 372-378, 2004
3632004
Diagnosis of AIDS-related focal brain lesions: a decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays …
A Antinori, A Ammassari, A De Luca, A Cingolani, R Murri, G Scoppettuolo, ...
Neurology 48 (3), 687-694, 1997
2511997
Class III β-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients
G Ferrandina, GF Zannoni, E Martinelli, A Paglia, V Gallotta, S Mozzetti, ...
Clinical Cancer Research 12 (9), 2774-2779, 2006
2452006
Expression of E-cadherin and β-catenin in human non-small cell lung cancer and the clinical significance
S Kase, K Sugio, K Yamazaki, T Okamoto, T Yano, K Sugimachi
Clinical Cancer Research 6 (12), 4789-4796, 2000
2432000
Increased cyclooxygenase-2 expression is associated with chemotherapy resistance and poor survival in cervical cancer patients
G Ferrandina, L Lauriola, MG Distefano, GF Zannoni, M Gessi, F Legge, ...
Journal of Clinical Oncology 20 (4), 973-981, 2002
2362002
Expression of CD133‐1 and CD133‐2 in ovarian cancer
G Ferrandina, G Bonanno, L Pierelli, A Perillo, A Procoli, A Mariotti, ...
International journal of gynecological cancer 18 (3), 506-514, 2008
2262008
Increased cyclooxygenase-2 (COX-2) expression is associated with chemotherapy resistance and outcome in ovarian cancer patients
G Ferrandina, L Lauriola, GF Zannoni, A Fagotti, F Fanfani, F Legge, ...
Annals of Oncology 13 (8), 1205-1211, 2002
1872002
Possible involvement of hMLH1, p16INK4a and PTEN in the malignant transformation of endometriosis
M Martini, M Ciccarone, G Garganese, C Maggiore, A Evangelista, ...
International journal of cancer 102 (4), 398-406, 2002
1652002
Cyclooxygenase‐2 expression in endometrial carcinoma
G Ferrandina, F Legge, FO Ranelletti, GF Zannoni, N Maggiano, ...
Cancer 95 (4), 801-807, 2002
1452002
Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil
M Ciaparrone, M Quirino, G Schinzari, G Zannoni, DC Corsi, FM Vecchio, ...
Oncology 70 (5), 366-377, 2006
1272006
p16ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri
G Negri, G Bellisano, GF Zannoni, F Rivasi, A Kasal, F Vittadello, ...
The American journal of surgical pathology 32 (11), 1715-1720, 2008
1112008
Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters
G Ferrandina, F Legge, E Martinelli, FO Ranelletti, GF Zannoni, L Lauriola, ...
British journal of cancer 92 (2), 271, 2005
1032005
CD133 antigen expression in ovarian cancer
G Ferrandina, E Martinelli, M Petrillo, MG Prisco, G Zannoni, S Sioletic, ...
BMC cancer 9 (1), 221, 2009
972009
p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis
V Masciullo, G Ferrandina, B Pucci, F Fanfani, S Lovergine, J Palazzo, ...
Clinical Cancer Research 6 (12), 4816-4822, 2000
922000
Follicular thyroid neoplasms can be classified as low-and high-risk according to HBME-1 and Galectin-3 expression on liquid-based fine-needle cytology
G Fadda, ED Rossi, M Raffaelli, A Pontecorvi, S Sioletic, F Morassi, ...
European journal of endocrinology 165 (3), 447-453, 2011
912011
Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix
P Cattani, GF Zannoni, C Ricci, S D'Onghia, IN Trivellizzi, A Di Franco, ...
Journal of clinical microbiology 47 (12), 3895-3901, 2009
882009
Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound—a European multicenter trial
E Epstein, A Testa, A Gaurilcikas, A Di Legge, L Ameye, V Atstupenaite, ...
Gynecologic oncology 128 (3), 449-453, 2013
852013
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker?
F Bussu, M Sali, R Gallus, VG Vellone, GF Zannoni, R Autorino, ...
British journal of cancer 108 (5), 1157, 2013
742013
BRAF (V600E) mutation analysis on liquid‐based cytology‐processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid …
ED Rossi, M Martini, S Capodimonti, CP Lombardi, A Pontecorvi, ...
Cancer cytopathology 121 (6), 291-297, 2013
732013
Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer
G Ferrandina, FO Ranelletti, V Gallotta, E Martinelli, GF Zannoni, M Gessi, ...
Gynecologic oncology 98 (3), 383-389, 2005
722005
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20